Stay updated on Fasinumab Long-Term Safety in OA Clinical Trial
Sign up to get notified when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.

Latest updates to the Fasinumab Long-Term Safety in OA Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record is displayed with details about the fasinumab study, including its design, eligibility criteria, locations, outcomes, publications, and study documents.SummaryDifference100%

- Check9 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check16 days agoChange DetectedA sitewide banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check51 days agoChange Detected- The study page now loads a 403 Forbidden page with a minimal header/footer instead of the study details for NCT02683239. - This indicates an access/load error that prevents viewing the trial information on that URL.SummaryDifference17%

Stay in the know with updates to Fasinumab Long-Term Safety in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.